You are here

Synthon Pharmaceuticals

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

Yahoo

Mon, 08/3/15 - 09:09 am

Synthon Pharmaceuticals

multiple sclerosis

Could This 1 Lawsuit Destroy Biogen Idec Stock?

Motley Fool

Tue, 07/22/14 - 05:08 pm

multiple sclerosis

Synthon Pharmaceuticals

Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab

Pipeline Review

Sun, 03/25/12 - 12:39 pm

Synthon Pharmaceuticals